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Background: Nausea is a common and disabling symptom of migraine. The origin of nausea is not well
understood although functional connections between trigeminal neurons and the nucleus tractus solitarius may
explain occurrence of nausea with pain. However, nausea occurs as a premonitory symptom in about a quarter of
patients, suggesting that a primary brain alteration unrelated to the experience of pain may be the reason for
nausea.
Methods: We performed positron emission tomography scans with H2
15O PET in premonitory phase of
nitroglycerin-induced migraine and compared patients with and without nausea.
Results: The results showed activation in rostral dorsal medulla and periaqueductal grey (PAG) in the nausea group,
which was absent in the no nausea group. The rostral dorsal medullary area included the nucleus tractus solitarius,
dorsal motor nucleus of the vagus nerve and the nucleus ambiguus, all of which are thought to be involved in
brain circuits mediating nausea.
Conclusions: The results demonstrate that nausea can occur as a premonitory symptom in migraine, independent
of pain and trigeminal activation. This is associated with activation of brain structures known to be involved in
nausea. We conclude that nausea is a centrally driven symptom in migraine.
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Nausea is a common and disabling symptom of mi-
graine, which is listed in the International Classification
of Headache Disorders-III-beta (ICHD-III-beta) as a key
symptom of an attack [1]. The neurobiology of nausea in
migraine is not well understood. Nausea is often associ-
ated with the pain in migraine and in this regard, con-
nections between trigeminal neurons and nucleus
tractus solitarius (NTS) are thought to explain the oc-
currence of nausea with headache [2]. However, nausea
can already be present in the premonitory phase, before
the appearance of headache.
In a previous study, nausea in the premonitory phase
correctly predicted headache in a quarter of migraineurs
[3]. The presence of nausea before pain suggests it can
occur independent of pain. Premonitory symptoms rep-
resent the earliest clinical change in migraineurs.* Correspondence: peter.goadsby@kcl.ac.uk
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in any medium, provided the original work is pPremonitory symptoms, such as tiredness, difficulty in
concentration, mood changes, yawning and cravings,
suggest the origin of the problem is likely to be within
the brain, and therefore, nausea could also be a predom-
inantly centrally driven symptom. We hypothesized that
central brain structures involved in nausea and emesis,
in particular, the NTS, is activated in migraine patients
who experience nausea in the absence of pain in the pre-
monitory phase. We conducted positron emission tom-
ography (PET) scans as a marker of neuronal activity in
the premonitory phase of migraine to be able to com-
pare patients with and without nausea.Methods
Patients included in this study were screened for an
over-arching investigation of the premonitory phase of
GTN-induced migraine [4]. After completion of PET
scans, a pre-planned sub-group analysis was conducted
between patients with and without nausea in the pre-
monitory phase.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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We conducted telephone interviews, after advertise-
ments in local media, to select patients who met the in-
clusion criteria: age 18–65 years, migraine without aura
[5], less than fifteen days of headache a month, premoni-
tory symptoms before headache [3], no major medical
conditions and not on preventive drugs for migraine or
any other regular medications, which could confound
the study. We excluded patients with migraine aura to
prevent confusion with premonitory symptoms, as both
usually occur before headache. The study was approved
by the UCSF Committee on Human Research and the
Radiation Safety Committee. Written informed consent
was obtained from all patients before study inclusion.
Screening
We initially screened one-hundred and twenty-five pa-
tients. Twenty-seven satisfied the inclusion criteria and
agreed to participate. The most common reasons for
non-inclusion were: headache for more than fifteen days
a month (n = 45), confounding medications (n = 29),
migraine aura (n = 12), and patients unwilling due to ra-
diation risk (n = 8); less common reasons for exclusion
are included in a table (Table 1).
GTN triggering
These twenty-seven patients were invited for the first
visit during which we infused intravenous GTN 0.5 mi-
crograms × kg−1 × minute−1 over 20 minutes to select
patients who responded with premonitory symptoms
followed by a delayed headache resembling their mi-
graine headache, hereafter referred to as migraine head-
ache [6]. Details about headache and associated symptoms
were asked initially every five minutes and then less fre-
quently (Table 2). Blood pressure, oxygen saturation and
pulse rate were recorded initially every five minutes and
then less frequently. Of these twenty-seven patients, eight-
een had migraine headache. Out of these eighteen, thir-
teen patients had premonitory symptoms before migraineTable 1 Miscellaneous reasons for non-inclusion after
telephonic screening
Reasons for non-inclusion n
1 History not compatible with ICHD defined migraine 6
2 No premonitory symptoms before headache during
spontaneous attacks
5
3 Difficulty contacting patients after initial eligibility 4
4 Incomplete screenings 4
5 Outside age-range 2
6 Patient refusals due to GTN risk 3
7 Patient refusals due to – time factors, inadequate compensation,
lack of interest or unwilling to get induced migraine
7
Total 31headache. These thirteen patients were invited for PET
scans at least seven days after the first GTN infusion.
PET scanning
All patients had been pain free at least 72 hours before
the PET scans. The procedure for GTN infusion and
recording of symptoms was repeated as on the first oc-
casion. We performed PET scans with the GE Discovery
VCT PET/CT system (Waukesha, WI, United States) in
three-dimensional mode with septa retracted. All subjects
were instructed to keep their eyes closed during the scans.
The subjects were positioned in the PET scanner, and their
head immobilized with standard immobilization straps
and a low dose CT scan was performed for attenuation
correction. CT scans for attenuation correction were
repeated when patients exited the scanner for relaxation
between conditions. An antecubital vein cannula was used
to administer the tracer, 370 MBq of H2
15O, which was re-
peated before each scan. The activity was infused into sub-
jects over twenty seconds at a rate of 10 ml/min. The
interval between scans was at least ten minutes allowing
an interval of five half-lives of H2
15O (t1/2 = 122 seconds).
The PET data were acquired dynamically and summed for
one 90-second frame beginning five seconds before the
peak of the head curve.
Scans
Each patient had scans in three conditions – baseline
(pain free), premonitory phase (pain free) and migraine
headache. We could not randomize the order of the
scans since the premonitory and migraine headache
phases were triggered by the GTN infusion sequentially.
We planned to do three scans in each condition. How-
ever, the number of scans in the premonitory phase
depended on how soon the migraine headache devel-
oped. Soon after the initiation of GTN, patients had a
mild headache that lasted for a mean of 23 ± 7 minutes
(range 11–32). Premonitory scans were performed after
the GTN headache had completely subsided, premoni-
tory symptoms were present and the migraine headache
had not appeared. The mean time for the first premoni-
tory scan after initiation of GTN infusion was 56 ± 16 mi-
nutes (range 38–80). Migraine scans were performed
when the migraine headache (delayed headache) was
moderate or severe. The mean time for the first migraine
scan after initiation of GTN infusion was 125 ± 41 minutes
(range 89–225). Subsequent scans in the premonitory and
migraine phases were conducted at approximately 10 mi-
nute intervals. Out of thirteen, ten patients had at least
one scan during the premonitory period when no pain
was present. Therefore, only these ten patients’ scans were
used for the final analysis.
All the ten patients had three scans each during base-
line. In the premonitory phase, five patients had two
Table 2 Recording of symptoms after triggering with GTN
A B
Time points after GTN
infusion initiation
Symptoms queried at each time point











Recording of symptoms was continued at 10–15 minute intervals until all
scans were complete.
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had three and one patient had four scans. In the mi-
graine headache phase, five patients had three scans
each, two patients had two, one patient had one, one pa-
tient had four and one patient had five scans. Images
were reconstructed by 3D iterative reconstruction
(3DIR) provided by the manufacturer into 47 image
planes (separation 3.27 mm) and into a 128 × 128 pixel
image matrix (pixel size 2.1 × 2.1 mm2).
Statistical analysis
SPM2 (www.fil.ion.ucl.ac.uk/spm) was used for data pre-
processing and statistical analysis [7]. Images were rea-
ligned with the first as reference and stereotactically
normalized into MNI space. The normalized images
were smoothed with a Gaussian filter of 8 mm full width
at half-maximum. Statistical parametric maps were de-
rived with pre-specified contrasts, comparing rCBF (Re-
gional Cerebral Blood Fow) during states of interest.
Using the brainstem as the region of interest (ROI), we
specifically looked for differences in the two groups:
nausea and no nausea in the premonitory phase, in areas
known to be involved in nausea like the rostral dorsal
medulla containing the NTS, dorsal motor nucleus of
the vagus nerve, nucleus ambiguus and area postrema
[8-10]. Since there are no known MNI coordinates
representing these areas, we used the human atlas by
DeArmond [11] to approximate the location of activa-
tions. We initially carried out a paired t-test to study ac-
tivations in the premonitory phase > baseline, in the
nausea group, and then carried out the same procedure
separately for the no-nausea group. Finally, we used a
two sample t-test to study activations in the premonitory
phase > baseline, in the nausea group > no nausea group.As we had a strong hypothesis regarding activations in
the lower brainstem in the nuclei noted above, we ini-
tially looked at the results with a threshold p < 0.05, un-
corrected for multiple comparisons. Activated clusters in
the above-mentioned areas were selected. We then car-
ried out a small volume correction (SVC) for multiple
comparisons within a sphere of radius 5 mm, centered
at co-ordinates representing maxima within this cluster.
P < 0.05 after false discovery rate (FDR) correction for
multiple comparisons was deemed significant.
Results
The premonitory symptoms in the two groups during
the scanning session are listed in Table 3.
Three patients had nausea and seven did not have nau-
sea in the premonitory phase during the scanning session.
The age range was 19–47 years (32 ± 10, mean ± SD). Pa-
tients in the two groups did not differ in age (unpaired
tailed t-test, p = 0.6). There were two males in the nausea
group and one male in the no nausea group.
Comparing the premonitory scans > baseline scans in
the nausea group with an uncorrected p value threshold
of p < 0.05, we found brainstem activations in the rostral
dorsal medulla and the PAG. These results survived
SVC for multiple comparisons within a sphere of radius
5 mm centered at co-ordinates representing maxima
within that cluster. Comparing the premonitory scans >
baseline scans in the no-nausea group with an uncorrected
threshold of p < .05, we did not find activations in the
brainstem. Finally, comparing the premonitory scans >
baseline scans, in the nausea group > no-nausea group
with an uncorrected threshold of p < 0.05, we again found
activations in the dorsal rostral medulla and the PAG,
which survived SVC for multiple comparisons within a
sphere radius of 5 mm centered at co-ordinates represent-
ing maxima within that cluster (Figure 1 and Table 4). Re-
ferring to the atlas by DeArmond [11], the activations in
the rostral medulla coincided with the NTS, dorsal motor
nucleus of the vagus nerve and nucleus ambiguus.
Discussion
Our findings link nausea in the premonitory phase of
migraine to activation of central structures in the rostral
dorsal medulla and the PAG. The activation in the ros-
tral dorsal medulla included the NTS, dorsal motor nu-
cleus of vagus and nucleus ambiguus, all of which are
known to be important central mediators of nausea. Pri-
mary activation of these nuclei exclusively in patients
who experience nausea before the appearance of head-
ache and trigeminal activation, demonstrates that nausea
can be a centrally driven symptom in some patients.
Various brain areas are involved in nausea and emesis
without there being a single ‘emesis center’. Areas in the
dorsal rostral medulla, including all the areas activated
Table 3 Premonitory symptoms in GTN-induced migraine
during the scanning session
Nausea group
Patient number Premonitory symptoms
1 Nausea, photophobia, thirst
2 Nausea, photophobia, tiredness, mood changes
3 Nausea, tiredness, neck stiffness, urination, thirst,
dry mouth
No nausea group
Patient number Premonitory symptoms
1 Tiredness, neck stiffness, yawning
2 Photophobia, tiredness, neck stiffness,
mood changes
3 Urination, thirst, neck stiffness
4 Yawning, urination, thirst
5 Tiredness
6 Photophobia, neck stiffness, tiredness
7 Photophobia, neck stiffness, thirst
Figure 1 Areas of increased rCBF in the premonitory phase of
migraine in patients with nausea > patients without nausea.
Areas of increased rCBF in the premonitory phase > baseline are
depicted in patients with nausea > patients without nausea. The
results are superimposed on an anatomical reference derived from a
representative T1-weighted MRI of one of the patients in this study.
The colour bar indicates the colour coding for the Z scores. Images
are displayed in radiological convention i.e. left side of image is right
side of brain. A threshold of p < 0.01, uncorrected, was used for
display purposes.
Table 4 MNI co-ordinates and statistical values of a priori
areas with increased rCBF in the premonitory phase as
compared to baseline in patients with nausea more than
patients without nausea
Brain regions MNI coordinates Z score P value
X Y Z
Left rostral dorsal medulla −6 −30 −45 2.23 < 0.03*
Left PAG −6 −30 −9 2.18 < 0.04*
The co-ordinates represent the maxima within an activation cluster.
*after SVC for multiple comparisons using false detection rate (FDR) within a
sphere of radius 5 mm centered at the given co-ordinates.
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portant. The NTS plays a coordinating role and receives
information from vagal afferents and the area postrema
[8-10]. The nucleus ambiguus is involved in the respira-
tory related components of vomiting [12]. The dorsal
motor nucleus of the vagus nerve causes relaxation of
the lower esophageal sphincter and the gastric fundus,
both of which precede emesis [13]. The PAG modulates
the function of the nucleus ambiguus [14]. The PAG can
also be associated with sympathetic system activation
seen during nausea and emesis [15,16]. Cardiovascular
and respiratory regulation by the PAG is mediated through
ascending projections to the dorso-medial hypothalamus
and descending projections to the ventral medulla [17].
The NTS has afferent and efferent connections with the
paraventricular nucleus of the hypothalamus suggesting a
role in autonomic control [18]. The paraventricular and
dorso-medial hypothalamic nuclei form the principal cen-
tral afferent input to the area postrema [10]. Brain areas
rostral to the nucleus ambiguus are not essential for vomit-
ing, but may initiate vomiting under certain circumstances
such as to cancer chemotherapy or psychogenic vomiting
[19]. In this regard, electrical stimulation of the preoptic
and medial nuclei of the hypothalamus, the nucleus anter-
ior ventralis of the thalamus and limbic cortical areas, such
as the amygdala and hippocampus, have been shown to in-
duce vomiting [20]. When we compared premonitory scans
of all patients (with and without nausea) against baseline, as
we have reported [4], we found activations in the dorsal
and lateral regions of the hypothalamus but not in anterior
thalamus, hippocampus or amygdala. Therefore, consider-
ing the connections between the NTS and area postrema
with the hypothalamus, the hypothalamus may play a direct
or indirect role in nausea in the premonitory phase. The
absence of hypothalamic activation in the nausea group
could be due to low number of patients.
We cannot be certain that activation in the rostral
caudal medulla itself causes nausea and vomiting or al-
ternatively these areas are secondarily activated by other
sub-cortical or cortical areas. However, the important
finding is that the medullary areas are activated before
the appearance of pain and hence do not represent a
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lieve that nausea is centrally generated within the brain
in the premonitory phase of migraine. Worsening of
nausea during headache is likely to be due to the activa-
tion of functional connections between the trigemino-
vascular neurons and the NTS [2,21].Limitations
It needs to be emphasized that studying nausea in mi-
graine is very difficult, because patients are lying immo-
bilized in the scanner and nausea potentially carries the
risk of vomiting with aspiration. No neuroimaging study
has specifically addressed nausea in migraine to date.
We used data where nausea was recorded, although it
was not the main outcome of the principal study. The
number of patients in this pilot study was small, espe-
cially in the nausea group and group sizes are not bal-
anced. However, each patient had three scans in baseline
and between one - three scans in the premonitory phase.
We have previously used a similar design using H2
15O
PET with multiple scans in baseline and spontaneous
migraine states and found meaningful results with five
subjects [22]. Despite the small number in this study,
the absence of activation of the NTS and surrounding
areas in the no-nausea group and the presence of activa-
tion in these areas in the nausea group indicates that
these areas are activated when patients experience nau-
sea in the premonitory phase. Also, the results con-
firmed the a priori hypothesis that these areas would be
activated. A drawback of PET studies is the low spatial
resolution of the technique, which makes accurate delin-
eation of specific nuclei difficult. Due to the inherent
low spatial resolution of PET, and smoothing proce-
dures, we cannot be certain of not missing any activation
in smaller structures. Since we have not compared our
findings with patients with nausea due to other reasons,
we cannot be certain if the results are specific to the
premonitory phase of migraine.Conclusion
We conclude that occurrence of nausea in the premoni-
tory phase of migraine is associated with activation of the
NTS, dorsal motor nucleus of vagus, nucleus ambiguus
and the PAG, in the absence of pain, and hence likely
represents a primary event. This does not exclude its
augmentation by trigeminal nociceptive activation as an
additional pathophysiological mechanism. Future research
looking into more effective anti-nausea medications for
migraine should concentrate on these central sites.Competing interests
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